{
    "medicine_id": "9a8e663167c2bd3ff57070fe27f8321e837d12c7",
    "platform_id": "DB05491",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v ATN 161",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in brain cancer and cancer tumors unspecified",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "ATN 161 is a non RGD based integrin binding peptide targeting alpha 5 beta 1 and alpha v beta 3 It inhibits the migration and adhesion of particular integrins on activated endothelial cells that play a critical role in tumor angiogenesis Since the over expressed integrins and hyper vasularized tissue is common across many cancer types this treatment is expected to be indicated for many different cancers",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}